Spebrutinib

Item number	Size	Delivery time	Price
TGM-T2603-2mg	2 mg	7 - 10 business days*	37.00€
TGM-T2603-5mg	5 mg	7 - 10 business days*	54.00€
TGM-T2603-1mL	1 ml	7 - 10 business days*	57.00€
TGM-T2603-10mg	10 mg	7 - 10 business days*	77.00€
TGM-T2603-25mg	25 mg	7 - 10 business days*	100.00€
TGM-T2603-50mg	50 mg	7 - 10 business days*	125.00€
TGM-T2603-100mg	100 mg	7 - 10 business days*	206.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Spebrutinib (LMK-435) is an orally bioavailable, selective inhibitor of Bruton's... more

Close menu

Product information "Spebrutinib"

Description: Spebrutinib (LMK-435) is an orally bioavailable, selective inhibitor of Bruton's agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity. Target: Src, BTK. Smiles: COCCOc1ccc(Nc2ncc(F)c(Nc3cccc(NC(=O)C=C)c3)n2)cc1. References: Evans E, et al. ASH Annual Meeting, 2011 San Diego, CA.

Keywords:	AVL-292, LMK-435, CC-292
Supplier:	TargetMol
Supplier-Nr:	T2603

Properties

Application:	Targets Bruton agammaglobulinemia tyrosine kinase [EC:2.7.10.2] (BTK)
MW:	423.44 D
Formula:	C22H22FN5O3
Format:	32160405

Database Information

CAS :	1202757-89-8\| Matching products
KEGG ID :	K07370 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Spebrutinib"

Write a review